PaulJamesBeisswengerMD

Diabetes

Professor, Medicine, Geisel School of Medicine

Dr. Beisswenger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
16 Cavendish Ct
Journey Biosciences
Lebanon, NH 03766
Phone+1 603-996-1576

Dr. Paul Beisswenger is an endocrinologist in Lebanon, NH. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 53 years. He specializes in diabetes and after many years of research on diabetic complications, he has started a company that offers a blood test that predicts risk of diabetic kidney disease.

University of Pennsylvania Health SystemChief Residency, Internal Medicine, 1969 - 1970
Harvard Medical SchoolPost-Doctoral Fellowship, 1967 - 1969
University of Pennsylvania Health SystemResidency, Internal Medicine, 1965 - 1967
Perelman School of Medicine at the University of PennsylvaniaClass of 1964

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

PubMed

334 citations
Metformin reduces systemic methylglyoxal levels in type 2 diabetes.
Paul J. Beisswenger, Scott K. Howell, Allison D. Touchette, Sundeep Lal, Benjamin S. Szwergold
Diabetes. 1999-01-01
125 citations
Metformin inhibition of glycation processes
Paul J. Beisswenger, D. Ruggiero-Lopez
Diabetes & Metabolism. 2003-09-01
396 citations
Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases ...
Moritsugu Shinohara, Paul J. Thornalley, Ida Giardino, Paul J. Beisswenger, Suzanne R. Thorpe
The Journal of Clinical Investigation. 1998-03-01

Precision Diabetes, LLC, Presents Data on Novel, Predictive Tests for Diabetes Complications at American Diabetes Association (ADA) Research Symposium: Advancing Precision Diabetes MedicineOctober 8th, 2019
Johnson & Johnson Innovation Announces Winners of the Singapore QuickFire Challenge in Collaboration with ETPL and SMARTSeptember 22nd, 2017

Glycation And MU Dicarbonyls In Diabetic ComplicationsNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
Enzymatic Controls Of Nonenzymatic GlycationNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2005